For the year ending 2025-12-31, SRPT has $3,349,703K in assets. $2,209,081K in debts. $801,282K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 801,282 | |||
| Short-term investments | 138,368 | |||
| Accounts receivable, net | 398,233 | |||
| Inventory | 914,744 | |||
| Manufacturing-related deposits and prepaids | 113,455 | |||
| Other current assets | 171,856 | |||
| Total current assets | 2,537,938 | |||
| Property and equipment, gross | 626,040 | |||
| Less accumulated depreciation | 280,472 | |||
| Less accumulated impairment loss | 443 | |||
| Property and equipment, net | 345,125 | |||
| Right of use assets | 125,495 | |||
| Non-current inventory | 184,543 | |||
| Non-current investments | 1,048 | |||
| Other non-current assets | 155,554 | |||
| Total assets | 3,349,703 | |||
| Accounts payable | 280,841 | |||
| Accrued expenses | 359,659 | |||
| Deferred revenue, current portion | 443,397 | |||
| Other current liabilities | 11,393 | |||
| Total current liabilities | 1,095,290 | |||
| Long-term debt | 828,974 | |||
| Lease liabilities, net of current portion | 199,378 | |||
| Deferred revenue, net of current portion | 83,910 | |||
| Contingent consideration | 0 | |||
| Other non-current liabilities | 1,529 | |||
| Total liabilities | 2,209,081 | |||
| Common stock, 0.0001 par value, 198,000,000 shares authorized 105,615,096 and 104,964,220 issued and outstanding, respectively, at december 31, 2025 and 96,900,496 issued and outstanding at december 31, 2024 | 11 | |||
| Treasury stock, at cost, 650,876 and 0 shares at december 31, 2025 and december 31, 2024, respectively | 25,263 | |||
| Additional paid-in capital | 6,042,586 | |||
| Accumulated other comprehensive (loss) income, net of tax | 272 | |||
| Accumulated deficit | -4,876,984 | |||
| Total stockholders equity | 1,140,622 | |||
| Total liabilities and stockholders equity | 3,349,703 | |||
Sarepta Therapeutics, Inc. (SRPT)
Sarepta Therapeutics, Inc. (SRPT)